HistoSonics Announces First Patient Treated in European Clinical Trial
Otto von Guericke University Clinic Magdeburg is first to treat patient with liver tumors in company’s #HOPE4LIVER Europe Study
June 7, 2021
CLINICAL TRIALS, STUDIES, REGISTRIES, DATA
View the latest clinical trials, studies, data, and updates.
2,000,000 TWO2 Treatments Milestone Reached as TWO2 Study Is Highlighted in Systemic Review of Topical Oxygen Therapies
“This is another enormous milestone for our company and a testament to the ease-of use and durable clinical efficacy of TWO2 therapy, as well as to the tenacity of our entire dedicated care team. AOTI
June 7, 2021
Aethlon Medical Publishes Case Studies of Two Critically Ill COVID-19 Patients Treated with the Hemopurifier®
Both patients were given access to Hemopurifier® treatment through Emergency Use. The manuscript is titled “Removal of COVID-19 Spike Protein, Whole Virus, Exosomes and Exosomal microRNAs by the Hemopurifier® Lectin-Affinity Cartridge in Critically Ill Patients with COVID-19 Infection” and was published in Research Square.
June 3, 2021
IRRAS Announces Publication of a Case Report from Buffalo General Medical Center
IRRAflow Intraventricular Hemorrhage (IVH) Case Report Published in Cureus Journal of Medical Science. Publication also documents the ability to deliver targeted thrombolytic medication via IRRAflow’s recurring irrigation for the first time in the peer-reviewed scientific literature
May 28, 2021
FAST BioMedical Successfully Completes Open-Label Proof-of-Concept Study for Measuring Interstitial Volume
Conducted at the Richard L. Roudebush VA Medical Center in Indianapolis, the study evaluated the safety, tolerability and performance of the FAST Technology in chronic dialysis patients with extremely reduced or no kidney function.
May 26, 2021
Biospectal Announces Two Independent Global Health Research and Validation Studies Using Biospectal OptiBP™ Blood Pressure Measurement App
Funded by the Bill & Melinda Gates Foundation and Global Grand Challenges Canada’s Saving Lives at Birth initiative, the two research and validation studies include the integration of Biospectal OptiBP and focus on the routine measurement of blood pressure as well as assessment of hypertension during pregnancy
May 20, 2021
